title: Pyoderma gangrenosum with severe cutaneous and oral involvement.
authors.forename: Angelo V
authors.initials: AV
authors.lastname: Marzano
authors.forename: Silvia
authors.initials: S
authors.lastname: Alberti-Violetti
authors.forename: Rolando
authors.initials: R
authors.lastname: Crippa
authors.forename: Francesca
authors.initials: F
authors.lastname: Angiero
authors.forename: Gianluca
authors.initials: G
authors.lastname: Tadini
authors.forename: Carlo
authors.initials: C
authors.lastname: Crosti
mesh_terms: D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001494:Baths; D003879:Dermatologic Agents / Q000627:therapeutic use; D005885:Gingival Hyperplasia / Q000209:etiology* / Q000473:pathology; D006801:Humans; D008297:Male; D019226:Oral Ulcer / Q000150:complications* / Q000188:drug therapy; D011196:Potassium Permanganate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D017511:Pyoderma Gangrenosum / Q000150:complications* / Q000473:pathology / Q000628:therapy; D016388:Tooth Loss / Q000209:etiology
chemical_list: D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D011196:Potassium Permanganate; D011241:Prednisone